by TractManager | May 30, 2023 | Emerging Technology Report
Viaskin Peanut is an investigational daily immunotherapy patch for treatment of peanut allergy in children aged 1 to 3 years. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 25, 2023 | Emerging Technology Report
The Alleviant (ALV1) System is a radiofrequency catheter used to create an implant-free interatrial shunt for the treatment of heart failure with preserved ejection fraction (HFpEF) or heart failure with mildly reduced ejection fraction (HFmrEF).If you have a Hayes...
by TractManager | May 23, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of female-to-male (FtM) gender-affirming surgery (GAS) for adolescents with gender dysphoria (GD).If you have a Hayes...
by TractManager | May 23, 2023 | Molecular Test Assessment
This report evaluates the impact of the Guardant360 CDx test (Guardant Health Inc.) as a companion diagnostic on patient survival.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 22, 2023 | Emerging Technology Report
Vyjuvek is a topical gene therapy indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.If you have a Hayes login, click here to...
Recent Comments